During the past decade, Klinikum Nord Frauenklinik conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Nord Frauenklinik" are "Breast Neoplasms" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Klinikum Nord Frauenklinik" in a lesser frequency.

Most popular intervention types in "Klinikum Nord Frauenklinik" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Herceptin" (1 trials), "liposomal doxorubicin" (1 trials), "paclitaxel" (1 trials) and "topotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Nord Frauenklinik" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Nord Frauenklinik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinikum Nord Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Nord Frauenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".